India is currently having a discussion on securing Pfizer’s messenger RNA vaccine as well as a number of other domestic and foreign COVID-19 vaccine candidates
American pharma company Pfizer is currently in discussions with the government to distribute its potential COVID-19 vaccine in India.
According to a Spokesperson for Pfizer who spoke to LiveMint, Pfizer believes that its candidate has the potential to be an important part of India’s early vaccine response.
“We remain committed to advance our dialogue with the Government of India to make this vaccine available for use in the country,” LiveMint quoted the spokesperson as saying.
According to the report, India is currently having a discussion on securing Pfizer’s messenger RNA vaccine as well as a number of other domestic and foreign COVID-19 vaccine candidates.
Pfizer could make up to 50 million vaccine doses in 2020, scaling up to 1.3 billion doses in 2021.
So far the American company does not have a distribution pact with any Indian company. It also does not have any agreement with Covax, the COVID-19 vaccine access initiative of Gavi and the World Health Organization (WHO).
The company has also developed detailed logistical plans and tools which will effectively transport the vaccine and will provide a method for its storage and continuous temperature monitoring, the spokesperson said, as per the report.
“We have experience working with customers in all markets and have developed comprehensive solutions to partner with countries to help in the deployment of this vaccine,” the spokesperson said.
First Published on Nov 10, 2020 09:15 pm